scholarly journals The use of clostridium botulinum toxin in palatal myclonus. A preliminary report

1993 ◽  
Vol 107 (3) ◽  
pp. 208-210 ◽  
Author(s):  
Shakeel R. Saeed ◽  
Gerald B. Brookes

Palatal myoclonus is a rare syndrome characterized by involuntary rhythmical movements of the soft palate giving rise to clicking objective tinnitus. The intrusive nature of the tinnitus prompts patients to seek medical advice but to date no single treatment modality has been shown to be consistently effective. We present three cases in whom various management regimes were unsuccessful and in whom botulinum toxin injection to the palatal muscles was undertaken. All three cases were rendered free of their tinnitus with complete abolition of the myoclonus. The questions of optimum dosage as well as frequency of injection will be answered as greater numbers are treated by this method.

1994 ◽  
Vol 108 (5) ◽  
pp. 380-382 ◽  
Author(s):  
Lydis Badia ◽  
Abhi Parikh ◽  
Gerald B. Brookes

AbstractTinnitus produced by synchronous repetitive contraction of the middle ear muscles (middle ear myoclonus) is a rare condition.We present six cases of middle ear myoclonus in whom different management regimes were successful. In two patients, the tinnitus was controlled by conservative measures. In one patient, whose tinnitus was associated with blepharospasm, significant improvement occurred following botulinum toxin injection into the ipsilateral orbicularis oculi. Three patients were cured by tympanotomy with stapedial and tensor tympani tendon section.The aetiology of this type of myoclonus remains unclear. The diagnosis is based on the history of involuntary and rhythmic clicking or buzzing tinnitus which is invariably unilateral. The primary differential diagnosis is palatal myoclonus whilst other local aural pathologies must be excluded by careful clinical assessment. Surgical section of these muscles via tympanotomy brings guaranteed relief when conservative measures fail.


2012 ◽  
Vol 63 (5) ◽  
pp. 391-392 ◽  
Author(s):  
Noemi Conill Tobías ◽  
Carlos de Paula Vernetta ◽  
Francisco Javier García Callejo ◽  
Jaime Marco Algarra

2017 ◽  
Vol 35 (3) ◽  
pp. 511-513 ◽  
Author(s):  
Saima Rashid ◽  
Amanda R. Fields ◽  
Steven J. Baumrucker

Post-thoracotomy pain syndrome (PTPS) is a traumatic neuropathy that can affect as many as 50% of patients undergoing thoracotomy. Patients are often refractory to conservative management and may require multiple analgesics for adequate pain control. Botulinum toxin, derived from Clostridium botulinum, has many uses in treating conditions involving spasticity, dystonia, chronic migraine, and a variety of pain disorders including neuropathies. Botulinum toxin type A injections may provide an alternative or adjunct to improve symptom management in patients with PTPS.


2007 ◽  
Vol 22 (10) ◽  
pp. 1484-1486 ◽  
Author(s):  
Pramod Kumar Pal ◽  
Ponnathpur Satish Lakshmi ◽  
Muninarayanappa Nirmala

Sign in / Sign up

Export Citation Format

Share Document